MedTrace Logo

Trans People Living With HIV Throughout Europe

NCT03922269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-12-23

No results posted yet for this study

Summary

The project will study a European cohort of individuals identifying themselves as transgender or non-binary and living with HIV.

The study will collect both qualitative data on this cohort and clinical data over an 18 month period. The study will investigate the success of HIV treatment for this cohort through the primary outcome measure of HIV viral load recorded in routine blood tests.

The results from this study will assist in informing future HIV treatment guidelines on the monitoring of HIV infection in transgender and non-binary individuals and assisting in the design of future interventional studies within this population.

Conditions

  • HIV Infections
  • Gender Identity
  • Human Immunodeficiency Virus

Sponsors & Collaborators

  • ViiV Healthcare

    collaborator INDUSTRY

  • Chelsea and Westminster NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Marta Boffito, MD, PhD · Chelsea and Westminster NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-11
Primary Completion
2025-12-17
Completion
2025-12-17

Countries

  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03922269 on ClinicalTrials.gov